Treatment-related hypertension (HTN) as a predictive biomarker for clinical outcomes in patients (pts) with advanced pancreas cancer (APCA) treated with bevacizumab (B): A pooled analysis of four prospective clinical trials.
Ludmila Katherine Martin
No relevant relationships to disclose
Lai Wei
No relevant relationships to disclose
Katherine Van Loon
No relevant relationships to disclose
Renuka V. Iyer
No relevant relationships to disclose
Shubham Pant
No relevant relationships to disclose
David R. Fogelman
No relevant relationships to disclose
Andrew H. Ko
No relevant relationships to disclose
Tanios S. Bekaii-Saab
Consultant or Advisory Role - Genentech/Roche